Understanding Fueling Challenges with GLP-1 Medications
Fueling your body adequately is crucial during any weight loss program that includes running. However, medications such as GLP-1 agonists might interfere with your ability to eat sufficiently. If you're using drugs like Ozempic or Wegovy, your hunger signals could be diminished, requiring careful pre-planning of meals to ensure proper nourishment.
GLP-1 Effects on Appetite and Digestion
GLP-1, or glucagon-like peptide 1, refers to agonists that include options like Ozempic and Wegovy. These drugs delay the processing of glucose, causing food to linger in the stomach for extended periods. Consequently, users often feel sated for longer durations, leading to reduced food intake. In some cases, appetite becomes so suppressed that individuals overlook the need to eat altogether.
Common Side Effects Associated with GLP-1s
In addition to appetite changes, those on GLP-1 medications may encounter unpleasant symptoms. These can include feelings of sickness, expulsion of stomach contents, tiredness, hardened stools, lightheadedness, and loose bowel movements. Such reactions might further complicate efforts to consume necessary nutrients.
Risks of Inadequate Fueling
With a compromised sense of hunger due to GLP-1 use, you might not consume the required energy for running performance. This shortfall can lead to deficiencies in essential elements like fiber, potentially causing constipation or bloating. Moreover, it heightens the chance of insufficient nutrition and disorders such as low energy availability (LEA) and relative energy deficiency in sport (RED-S). Severe calorie limitations accelerate weight reduction but erode lean tissue, encompassing bones and muscles, vital for robustness and vitality. To tackle extended runs successfully, adequate nourishment is essential.
